| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.41▼ | 11.41▼ | 11.41▼ | 10.35▲ | 7.32▲ |
| MA10 | 11.37▼ | 11.39▼ | 11.50▼ | 8.53▲ | 6.23▲ |
| MA20 | 11.52▼ | 11.66▼ | 10.76▲ | 6.75▲ | 4.25▲ |
| MA50 | 12.30▼ | 10.57▲ | 9.37▲ | 5.84▲ | 3.78▲ |
| MA100 | 10.95▲ | 9.15▲ | 8.23▲ | 3.96▲ | 2.07▲ |
| MA200 | 10.53▲ | 7.05▲ | 5.68▲ | 3.44▲ | 7.03▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.014▲ | -0.123▼ | -0.067▼ | 0.616▲ | 0.678▲ |
| RSI | 45.208▼ | 51.075▲ | 54.042▲ | 68.876▲ | 70.903▲ |
| STOCH | 46.888 | 39.156 | 25.471 | 53.307 | 52.155 |
| WILL %R | -68.675 | -79.200▼ | -73.061 | -36.627 | -28.160 |
| CCI | -42.417 | -77.240 | -34.689 | 79.195 | 207.397▲ |
|
Thursday, June 04, 2026 05:40 AM
SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel ...
|
|
Wednesday, June 03, 2026 05:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/06/26 | 10.16 | 11.98 | 10.16 | 11.44 | 181,019 |
| 04/06/26 | 13.52 | 15.74 | 10.50 | 11.54 | 8,792,109 |
| 03/06/26 | 8.89 | 11.15 | 8.40 | 9.46 | 169,011 |
| 02/06/26 | 9.96 | 10.1799 | 8.70 | 8.73 | 140,168 |
| 01/06/26 | 10.00 | 11.10 | 8.562 | 10.59 | 380,292 |
| 29/05/26 | 9.86 | 10.04 | 8.40 | 9.81 | 818,549 |
| 28/05/26 | 13.22 | 15.65 | 10.1001 | 10.55 | 35,495,167 |
| 27/05/26 | 4.4902 | 4.4902 | 4.28 | 4.39 | 2,571 |
| 26/05/26 | 4.47 | 4.69 | 4.38 | 4.475 | 4,075 |
| 22/05/26 | 4.25 | 4.44 | 4.10 | 4.27 | 19,461 |
|
|
||||
|
|
||||
|
|